1. Home
  2. AVIR vs BKTI Comparison

AVIR vs BKTI Comparison

Compare AVIR & BKTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$3.61

Market Cap

266.4M

Sector

Health Care

ML Signal

HOLD

Logo BK Technologies Corporation

BKTI

BK Technologies Corporation

HOLD

Current Price

$76.57

Market Cap

244.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVIR
BKTI
Founded
2012
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
266.4M
244.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
AVIR
BKTI
Price
$3.61
$76.57
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$74.00
AVG Volume (30 Days)
397.2K
40.2K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
136.69
EPS
N/A
3.30
Revenue
N/A
$82,558,000.00
Revenue This Year
N/A
$12.00
Revenue Next Year
N/A
$11.30
P/E Ratio
N/A
$23.92
Revenue Growth
N/A
10.12
52 Week Low
$2.46
$26.20
52 Week High
$4.02
$86.24

Technical Indicators

Market Signals
Indicator
AVIR
BKTI
Relative Strength Index (RSI) 64.59 58.33
Support Level $3.34 $72.81
Resistance Level $3.63 $80.72
Average True Range (ATR) 0.15 3.34
MACD 0.01 0.21
Stochastic Oscillator 86.18 57.74

Price Performance

Historical Comparison
AVIR
BKTI

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

About BKTI BK Technologies Corporation

BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.

Share on Social Networks: